Literature DB >> 27868035

Did the beneficial renal outcomes with vasopressin VANISH?

Gretchen L Sacha1, Simon W Lam1, Seth R Bauer1.   

Abstract

Entities:  

Year:  2016        PMID： 27868035      PMCID： PMC5104626          DOI： 10.21037/atm.2016.10.59

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  18 in total

1.  Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial.

Authors:  Anthony C Gordon; Alexina J Mason; Neeraja Thirunavukkarasu; Gavin D Perkins; Maurizio Cecconi; Magda Cepkova; David G Pogson; Hollmann D Aya; Aisha Anjum; Gregory J Frazier; Shalini Santhakumaran; Deborah Ashby; Stephen J Brett
Journal:  JAMA       Date:  2016-08-02       Impact factor: 56.272

2.  Renal microvascular effects of vasopressin and vasopressin antagonists.

Authors:  R M Edwards; W Trizna; L B Kinter
Journal:  Am J Physiol       Date:  1989-02

3.  Concomitant arginine-vasopressin and hydrocortisone therapy in severe septic shock: association with mortality.

Authors:  Christian Torgersen; Günter Luckner; Daniel C H Schröder; Christian A Schmittinger; Christopher Rex; Hanno Ulmer; Martin W Dünser
Journal:  Intensive Care Med       Date:  2011-07-21       Impact factor: 17.440

4.  Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock.

Authors:  James A Russell; Keith R Walley; Anthony C Gordon; D James Cooper; Paul C Hébert; Joel Singer; Cheryl L Holmes; Sangeeta Mehta; John T Granton; Michelle M Storms; Deborah J Cook; Jeffrey J Presneill
Journal:  Crit Care Med       Date:  2009-03       Impact factor: 7.598

5.  Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock.

Authors:  Lisa G Hall; Lance J Oyen; C Burcin Taner; Daniel C Cullinane; Thomas K Baird; Stephen S Cha; Mark D Sawyer
Journal:  Pharmacotherapy       Date:  2004-08       Impact factor: 4.705

6.  A comparison of initial monotherapy with norepinephrine versus vasopressin for resuscitation in septic shock.

Authors:  Mitchell J Daley; Ishaq Lat; Katherine D Mieure; Heath R Jennings; Jesse B Hall; John P Kress
Journal:  Ann Pharmacother       Date:  2013-02-27       Impact factor: 3.154

7.  The effects of vasopressin on acute kidney injury in septic shock.

Authors:  Anthony C Gordon; James A Russell; Keith R Walley; Joel Singer; Dieter Ayers; Michelle M Storms; Cheryl L Holmes; Paul C Hébert; D James Cooper; Sangeeta Mehta; John T Granton; Deborah J Cook; Jeffrey J Presneill
Journal:  Intensive Care Med       Date:  2009-10-20       Impact factor: 17.440

8.  High-dose vasopressin is not superior to norepinephrine in septic shock.

Authors:  Stefan Klinzing; Mark Simon; Konrad Reinhart; Donald L Bredle; Andreas Meier-Hellmann
Journal:  Crit Care Med       Date:  2003-11       Impact factor: 7.598

9.  Vasopressin versus norepinephrine infusion in patients with septic shock.

Authors:  James A Russell; Keith R Walley; Joel Singer; Anthony C Gordon; Paul C Hébert; D James Cooper; Cheryl L Holmes; Sangeeta Mehta; John T Granton; Michelle M Storms; Deborah J Cook; Jeffrey J Presneill; Dieter Ayers
Journal:  N Engl J Med       Date:  2008-02-28       Impact factor: 91.245

10.  Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury.

Authors:  Ravindra L Mehta; John A Kellum; Sudhir V Shah; Bruce A Molitoris; Claudio Ronco; David G Warnock; Adeera Levin
Journal:  Crit Care       Date:  2007       Impact factor: 9.097
View more
  1 in total

1.  Decreased renal cortical perfusion, independent of changes in renal blood flow and sublingual microcirculatory impairment, is associated with the severity of acute kidney injury in patients with septic shock.

Authors:  James Watchorn; Dean Huang; Kate Bramham; Sam Hutchings
Journal:  Crit Care       Date:  2022-09-01       Impact factor: 19.334
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.